Impact of Free Mobility on FDG Uptake in PET Scans

Launched by CENTRE HOSPITALIER RÉGIONAL D'ORLÉANS · Jan 28, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how moving around after receiving a special injection, called 18F-Fluorodeoxyglucose (FDG), affects the quality of a type of medical scan known as PET (Positron Emission Tomography). Normally, patients must stay still and rest for an hour after the injection before the scan begins, but this study aims to see if allowing patients to move freely during that time changes the images taken. Researchers hope to show that moving around doesn’t impact the scan quality, meaning patients could be more comfortable without affecting their results.

To participate in this trial, you need to be an adult who is scheduled for an FDG PET scan (but not for the brain). Unfortunately, some individuals are not eligible, including those who are bedridden, under legal guardianship, or pregnant. If you join, you can expect a similar experience to a regular PET scan, with the added opportunity to see if moving around makes a difference in the outcome. This study is not yet recruiting participants, but it’s an important step toward potentially improving the comfort of future patients during this procedure.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adults
• • 2. Patient referred for FDG PET (excluding brain PET) and carried out on an outpatient basis.
• Exclusion Criteria:
• • 1. Bedridden patients
• • 2. Protected person (under guardianship or curatorship)
• • 3. Persons under court protection
• • 4. Persons deprived of liberty
• • 5. Persons not affiliated to a social security scheme
• • 6. Pregnant or breast-feeding woman